Garri Zmudze Insights

CONTRIBUTED CONTENT

Garri contributes op-eds and original content for leading outlets across web3, health, startups, and more.

LinkedIn: What 60-year-old Ironman athletes tell us about our longevity

Longevity will transform how aging looks in society. It will add life to our years, especially later in life.
Contributed Content
·
20 min
·
March 23, 2023
LinkedIn: What 60-year-old Ironman athletes tell us about our longevity

LinkedIn: Take your first steps into the longevity community: Join us at ARDD

Events offer diverse industry actors to align on common goals and seek inspiration from other dedicated individuals. This year’s ARDD event will bring the longevity community together in Copenhagen.
Contributed Content
·
10 min
·
March 7, 2023
LinkedIn: Take your first steps into the longevity community: Join us at ARDD

Cointelegraph: Artificial intelligence, robots and blockchain deliver next-generation healthcare, today

Emerging technologies are revolutionizing medicine - person by person and pill by pill.
Contributed Content
·
5 min
·
February 16, 2023
Cointelegraph: Artificial intelligence, robots and blockchain deliver next-generation healthcare, today

EXPERT COMMENTARY

Garri is a leading voice for trending topics in the field of health and investing.

LongeVC Backs Interface Biosciences for Advancing Inflammatory Disease Drug Development with AI-Enabled Platform

LongeVC invests in Interface Biosciences, securing $3 million for pioneering pharmaceutical development from bacterial natural products, marking a strategic advancement towards critical IND-enabling studies
Expert Commentary
·
5 min
·
Jul 27
LongeVC Backs Interface Biosciences for Advancing Inflammatory Disease Drug Development with AI-Enabled Platform

BioSpectrum: Seeking the 'fountain of youth'

Garri founded the Longevity Science Foundation to fund the diverse treatments contributing to human longevity.
Expert Commentary
·
4 min
·
Jul 27
BioSpectrum: Seeking the 'fountain of youth'

Sifted: Purrsonalised health: The startups and VCs betting on pet genetics

Animal genetics market revenue is predicted to exceed $6.4bn by 2027. Here are some of the pet genetics startups to watch.
Expert Commentary
·
1 min
·
Jul 27
Sifted: Purrsonalised health: The startups and VCs betting on pet genetics

ANNOUNCEMENT

Stay up-to-date with the latest from Garri and the companies within his realm.

Longevity.Technology: The time is right for specialist Longevity investment

Garri Zmudze, Sergey Jakimov, and Ilya Suharenko launch a new fund for longevity research: LongeVC.
Announcements
·
2 min
·
Jul 27
Longevity.Technology: The time is right for specialist Longevity investment

Longevity.Technology: Basepaws acquisition – exploring longevity beyond human health

Garri was an angel investor in pet health company Basepaws. Its acquisition offers promising insights into the future of human longevity.
Announcements
·
7 min
·
Jul 27
Longevity.Technology: Basepaws acquisition – exploring longevity beyond human health

ARDD: Decentralized science and blockchain in aging research

Garri explains the Longevity Science Foundation's work as a nonprofit supporting a decentralized and transparent future of longevity research.
Announcements
·
4 min
·
Jul 27
ARDD: Decentralized science and blockchain in aging research

ALL RESOURCES

Content at the cutting-edge of health and technology.

LinkedIn: What 60-year-old Ironman athletes tell us about our longevity

Longevity will transform how aging looks in society. It will add life to our years, especially later in life.
Contributed Content
·
20 min
·
Nov 22
LinkedIn: What 60-year-old Ironman athletes tell us about our longevity

LinkedIn: Irresponsible chatbot AI, meet restrained biotech AI

AI has the power to level up our health and lifespans like never before. Leaders in the biotech sector have been working hard to ensure the responsible and ethical use of AI.
Contributed Content
·
15 min
·
Nov 22
LinkedIn: Irresponsible chatbot AI, meet restrained biotech AI

Cointelegraph: Generative AI can deliver life-changing disease treatments

Generative AI can improve our healthcare system with faster drug discovery and treat devastating diseases.
Contributed Content
·
6 min
·
Nov 22
Cointelegraph: Generative AI can deliver life-changing disease treatments

LinkedIn: Women at the forefront of longevity: Celebrating and investing in an inclusive future

Women help build a more inclusive longevity space. Their dedication, talent, and ability to make an impact stand out.
Contributed Content
·
10 min
·
Nov 22
LinkedIn: Women at the forefront of longevity: Celebrating and investing in an inclusive future

LinkedIn: Take your first steps into the longevity community: Join us at ARDD

Events offer diverse industry actors to align on common goals and seek inspiration from other dedicated individuals. This year’s ARDD event will bring the longevity community together in Copenhagen.
Contributed Content
·
10 min
·
Nov 22
LinkedIn: Take your first steps into the longevity community: Join us at ARDD

Clinical Leader: Decentralization, it's more than you think

Decentralization encourages transparency, inclusion, and new funding streams for clinical research.
Contributed Content
·
3 min
·
Nov 22
Clinical Leader: Decentralization, it's more than you think

Clinical Leader: Future Funding, Trial Success Necessitates Use Of AI

AI is markedly transforming clinical trials, from enhancing predictive capabilities and patient adherence insights to optimizing trial design and expediting drug development.
Contributed Content
·
1 min
·
Nov 22
Clinical Leader: Future Funding, Trial Success Necessitates Use Of AI

AgeTech World: Longevity Will Never Be a Magic Pill That Will Make Us Younger

I share my drive and LongeVC's strategic investments in advancing an ageless future, emphasising the need for standardised longevity practises and systemic health economics reform
Contributed Content
·
3 min
·
Nov 22
AgeTech World: Longevity Will Never Be a Magic Pill That Will Make Us Younger
© 2024